by Sue Robbins | Nov 22, 2020 | Migraine
In 2018 the FDA approved three new medications to treat migraine.1 These medications are known by the brand names Aimovig, Emgality, and Ajovy. All three medications are in a class called calcitonin gene-related peptide inhibitors (CGRPs). CGRPs developed to treat...
by Sue Robbins | Jan 6, 2020 | Migraine
There are now a number of medications that may prevent or alleviate migraines, as well as a wearable nerve-stimulating device that can be activated by a smartphone. If you live with or work with someone who suffers from migraine, there’s something very important you...
by Sue Robbins | Oct 4, 2019 | Migraine
The most important unmet need from my perspective is for a patient to get a diagnosis and [to determine] if their physician is capable of taking care of a patient with migraine. If a patient is having trouble getting good care from their physician, they need to find a...
